Melaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans

Medical Mycology

Volumn 38, Issue 5, 2000, Pages 355-362

  Hammer, K A ^a,b   Carson, C F ^a   Riley, T V ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Antifungal; Candida; Melaleuca; Tea tree

Indexed keywords

TEA TREE OIL;

ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CANDIDA ALBICANS; CONTROLLED STUDY; FUNGUS GROWTH; IN VITRO STUDY; INHIBITION KINETICS; NONHUMAN; TEA;

BACTERIA (MICROORGANISMS); CANDIDA; CANDIDA ALBICANS; EQUUS CABALLUS; FUNGI; MELALEUCA; MELALEUCA ALTERNIFOLIA;

EID: 0033785262     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/714030963     Document Type: Article

References (39)

1. Brophy JJ, Davies NW, Southwell IA, Stiff IA, Williams LR. Gas Chromatographie quality control for oil of Melaleuca terpinen-4-ol type (Australian tea tree). J Agric Food Chem 1989; 37: 1330-1335.
2. Carson CF, Riley TV. Antimicrobial activity of the essential oil of Melaleuca alternifolia. Lett Appl Microbiol 1993; 16: 49-55.
3. Osborne F, Chandler F. Australian tea tree oil. Canadian Pharm J 1998; 131: 42-46.
4. Nenoff P, Haustein U-F, Brandt W. Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro. Skin Pharmacol 1996; 9: 388-394.
5. Concha JM, Moore LS, Holloway WJ. Antifungal activity of Melaleuca alternifolia (tea-tree) oil against various pathogenic organisms. J Am Podiatr Med Assoc 1998; 88: 489-492.
6. Hammer KA, Carson CF, Riley TV. In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. J Antimicrob Chemother 1998; 42: 591-595.
7. Elsom GKF, Hide D. Susceptibility of methicillin-resistant Slaphylococcus aureus to tea tree oil and mupirocin. J Antimicrob Chemother 1999; 43: 427-428.
8. Hammer KA, Carson CF, Riley TV. Influence of organic matter, cations and surfactants on the antimicrobial activity of Melaleuca alternifolia (tea tree) oil in vitro. J Appl Microbiol 1999; 86: 446-452.
9. Tong MM. Altman PM, Barnetson RStC. Tea tree oil in the treatment of tinea pedis. Australas J Dermatol 1992; 33: 145-149.
10. Buck DS, Nidorf DM, Addino JG. Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. J Fam Pract 1994; 38: 601-605.
11. Jandourek A, Vaishampayan JK, Vazquez JA. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients. AIDS 1998; 12: 1033-1037.
12. Syed TA, Qureshi ZA, Ali SM, Ahmad S, Ahmad SA. Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream. Trop Med hit Health 1999; 4: 284-287.
13. Hazen KC. New and emerging yeast pathogens. Clin Microbiol Rev 1995; 8: 462-478.
14. Odds FC. Candida and Candidosis, 2nd edn. London; Baillière Tindall, 1988.
15. Ellepola AN, Samaranayake LP. The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans. J Oral Pathol Med 1998; 27: 213-219.
16. Sobel JD, Muller G, Buckley HR. Critical role of germ tube formation in the pathogenesis of candidal vaginitis. Infect Immun 1984; 44: 576-580.
17. Cutler JE. Putative virulence factors of Candida albicans. Annu Rev Microbiol 1991; 45: 187-218.
18. Kobayashi SD, Cutler JE. Candida albicans hyphal formation and virulence; is there a clearly denned role? Trends Microbiol 1998; 6: 92-94.
19. Gow NA. Germ tube growth of Candida albicans. Curr Top Med Mycol 1997; 8: 43-55.
20. International Organisation for Standardisation. ISO 4730 Oil of Melaleuca, Terpinen-4-ol Type (Tea tree oil). Geneva: International Organisation for Standardisation, 1996.
21. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A. Wayne, PA: NCCLS, 1997.
22. Finegold SM, Baron EJ (eds). Bailey and Scott's Diagnostic Microbiology. St Louis: The C. V. Mosby Group, 1986.
23. Warnock DW. Johnson EM, Burke J, Pracharktam R. Effect of methotrexate alone and in combination with antifungal drugs on the growth of Candida albicans. J Antimicrob Chemother 1989; 23: 837-847.
24. Chaffin WL. Effect of tunicamycin on germ tube and yeast bud formation in Candida albicans. J Gen Microbiol 1985; 131: 1853-1861.
25. Lynch ME, Kukuruga M, Nakeff A, Fidel PL, Sobel JD. Flow cytometric analysis of germ tube formation in Candida albicans. J Med Vet Mycol 1993; 31: 367-376.
26. Hubbard MJ, Sullivan PA, Shepherd MG. Morphological studies of N-acetylglucosamine induced germ tube formation by Candida albicans. Can J Microbiol 1985; 31: 696-701.
27. Odds FC. Cockayne A, Hayward J. Abbott AB. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae. J Gen Microbiol 1985; 131: 2581-2589.
28. Johnson EM, Richardson MD, Warnock DW. Effect of imidazole antifungals on the development of germ tubes by strains of Candida albicans. J Antimicrob Chemother 1983; 12: 303-316.
29. Ha KC. White TC. Effects of azole antifungal drugs on the transition from yeast cells to hyphae in susceptible and resistant isolates of the pathogenic yeast Candida albicans. Antimicrob Agents Chemother 1999; 43: 763-768.
30. Taniguchi M, Yano Y, Tada E, et al. Mode of action of polygodial, an antifungal sesquiterpene dialdehyde. Agric Biol Chem 1988; 52: 1409-1414.
31. Barel S, Yashphe J. Effect of the essential oil from Achillea fragrantissima on Escheriehia coli cells. Curr Microbiol 1989; 19: 337-341.
32. Cox S, Gustafson JE, Mann CM, et al. Tea tree oil causes K+ J sup leakage and inhibits respiration in Escheriehia coli. Lett Appl Microbiol 1998; 26: 355-358.
33. Sikkema J, de Bont JAM, Poolman B. Mechanisms of membrane toxicity of hydrocarbons. Microbiol Rev 1995; 59: 201-222.
34. Bard M, Albrecht MR, Gupta N, Guynn CJ, Stillwell W. Geraniol interferes with membrane functions in strains of Candida and Saccharomyces. Lipids 1988; 23: 534-538.
35. Kurtz MB, Douglas CM. Lipopeptide inhibitors of fungal glucan synthase. J Med Vet My col 1997; 35: 79-86.
36. Uribe S, Ramirez J, Pena A. Effects of β-pinene on yeast membrane functions. J Bacterial 1985; 161: 1195-1200.
37. Inouye S, Watanabe M, Nishiyama Y, Takeo K, Akao M. Yamaguchi H. Antisporulating and respiratory-inhibiting effects of essential oils on filamentous fungi. Mycoses 1998; 41: 403-410.
38. Boonchird C, Flegel TW. In vitro antifungal activity of eugenol and vanillin against Candida albicans and Cryptococcus neoformans. Can J Microbiol 1982; 28: 1235-1241.
39. Pena EF. Melaleuca ahernifolia oil, its use for trichomonal vaginitis and other vaginal infections. Obstet Gynecol 1962; 19: 793-795.